GFACX
Price
$72.66
Change
-$0.68 (-0.93%)
Updated
Aug 29 closing price
Net Assets
327.53B
LGLRX
Price
$51.91
Change
-$0.70 (-1.33%)
Updated
Aug 29 closing price
Net Assets
7.76B
Interact to see
Advertisement

GFACX vs LGLRX

Header iconGFACX vs LGLRX Comparison
Open Charts GFACX vs LGLRXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.66
Change-$0.68 (-0.93%)
VolumeN/A
Net Assets327.53B
Lord Abbett Growth Leaders R3
Price$51.91
Change-$0.70 (-1.33%)
VolumeN/A
Net Assets7.76B
GFACX vs LGLRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. LGLRX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and LGLRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 328B vs. LGLRX (7.76B). GFACX (0.00) and LGLRX (0.00) have matching dividends . GFACX was incepted earlier than LGLRX: GFACX (24 years) vs LGLRX (14 years). GFACX (1.36) is less costly to investors than LGLRX (1.15). LGLRX is a more actively managed with annual turnover of: 94.00 vs. GFACX (25.00). LGLRX has a lower initial minimum investment than GFACX: LGLRX (0) vs GFACX (250). LGLRX annual gain was more profitable for investors over the last year : 38.27 vs. GFACX (12.25). GFACX (27.47) and LGLRX (26.83) have equivalent 5 years return.
GFACXLGLRXGFACX / LGLRX
Total Expense Ratio1.361.15118%
Annual Report Gross Expense Ratio1.361.15118%
Fund Existence24 years14 years-
Gain YTD13.95916.11187%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets328B7.76B4,228%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.2538.2732%
Returns for 3 years48.2690.1354%
Returns for 5 years27.4726.83102%
Returns for 10 years83.02141.6659%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNIX69.45N/A
N/A
Janus Henderson Global Life Sciences I
FCNTX24.36N/A
N/A
Fidelity Contrafund
BRWBX26.45N/A
N/A
MFS Blended Research Growth Eq B
JACFX19.81N/A
N/A
JHancock Mid Cap Growth NAV
QSMLX19.15-0.12
-0.62%
AQR Small Cap Multi-Style I